Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
SPANDANA Q2 FY26 earnings call: Order Book | Arthneeti
Q2 FY26
934 crores versus Rs. Key concall takeaways from SPANDANA's Q2 FY26 earnings call — and how it ranks against sector peers.
15 Jul 2026
SPANDANA Q1 FY26 earnings call: Margins & Order Book | Arthneeti
Q1 FY26
Disbursements have improved, with July at INR 268 crores and early August picking up further, though still below Business As Usual (BAU) levels. Key concall…
15 Jul 2026
Iris Clothings Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
E-commerce contribution is around 8%, with plans to develop the company’s own website to increase digital sales in the future. Key concall takeaways from Iris…
15 Jul 2026
Iris Clothings Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Incremental capex of INR6-7 crores planned for stitching and finishing facilities to support growth. Key concall takeaways from Iris Clothings Ltd's Q4 FY25…
15 Jul 2026
SPANDANA Q3 FY25 earnings call: Margins & Order Book | Arthneeti
Q3 FY25
. Key concall takeaways from SPANDANA's Q3 FY25 earnings call — and how it ranks against sector peers.
15 Jul 2026
Synergy Green Industries Q4 FY25: Order Book ₹600 Cr | Arthneeti
Q4 FY25
The order book currently exceeds ₹600 crores, indicating strong demand. Key concall takeaways from Synergy Green Industries Ltd's Q4 FY25 earnings call — and…
15 Jul 2026
Solara Active Pharma Sciences Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Capacity utilization currently stands at 60%, indicating room for volume growth. Key concall takeaways from Solara Active Pharma Sciences Ltd's Q4 FY25…
15 Jul 2026
SOLARA Q3 FY25 earnings call: Order Book | Arthneeti
Q3 FY25
500 crores in 3-4 years. Key concall takeaways from SOLARA's Q3 FY25 earnings call — and how it ranks against sector peers.
15 Jul 2026
Zim Laboratories Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
INR 15–16 crores run rate in Q3 and Q4 FY '26. Key concall takeaways from Zim Laboratories Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
15 Jul 2026
Sirca Paints India Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Ongoing capex of about ₹9-10 crores to consolidate Wembley and Welcome facilities, integrating production and increasing polyurethane capacity. Key concall…
15 Jul 2026
Sirca Paints India Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Growth is driven by expanded geographic focus including North India (70% of revenues), Central India, South India, and new OEM partnerships. Key concall…
15 Jul 2026
Yasho Industries Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Volume growth of 30% observed currently, with confidence to maintain or improve this via diversified markets. Key concall takeaways from Yasho Industries Ltd's…
15 Jul 2026
Yasho Industries Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Q1 FY '26 showed 14% YoY growth; volumes grew by 33%, indicating strong operational momentum. Key concall takeaways from Yasho Industries Ltd's Q1 FY26…
15 Jul 2026
Tara Chand Infralogistic Solutions Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Growth drivers include **equipment rentals, specialized services, and the new Tarachand Metallix business** (which will add revenues independently beyond the…
15 Jul 2026
Tara Chand Infralogistic Solutions Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Specialized service contracts, contributing INR31 crores last year, will continue to grow and contribute to revenue. Key concall takeaways from Tara Chand…
15 Jul 2026
Shalby Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Implant business showing strong revenue growth: 65% growth last year and similar in FY '26, with a large $35 billion global market opportunity and geographic…
15 Jul 2026
Shalby Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Revenue increase of 4% from the Mohali hospital due to CGHS uptake was mentioned. Key concall takeaways from Shalby Ltd's Q2 FY26 earnings call — and how it…
15 Jul 2026
Shalby Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Shalby MedTech's standalone revenue for Q1 FY '26 grew 271% YoY to INR18.24 crores; consolidated revenue up 74.2% YoY to INR30.8 crores. Key concall takeaways…
15 Jul 2026
Macpower CNC Machines Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Order book shows 17% growth, with a strong pipeline of INR958 crores in bids. Key concall takeaways from Macpower CNC Machines Ltd's Q3 FY26 earnings call…
15 Jul 2026
Macpower CNC Machines Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
As of November 14, 2025, Macpower CNC Machines Limited's pending order book is INR 350 crore. Key concall takeaways from Macpower CNC Machines Ltd's Q2 FY26…
15 Jul 2026